by Heather Dillaway | Oct 21, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Yes, the hormone therapies prescribed for women in perimenopause and beyond have already been suspect. Especially after the initial Women’s Health Initiative (WHI) trial results in 2002 (but even before that), researchers documented the health risks associated with...
by Chris Hitchcock | Sep 8, 2010 | Menstruation
An open-access article published in PLOS Medicine yesterday, Dr. Adriane Fugh-Berman, associate professor in the Department of Physiology at Georgetown University Medical Center in Washington DC, presents an article describing the ways in which the pharmaceutical...
by Elizabeth Kissling | Aug 11, 2010 | Health Care, Menstruation, New Research, Ovulation
Fascinating new research from the National Institutes of Health finds that women’s cholesterol levels correspond with cyclic changes in estrogen levels. Total cholesterol levels can vary by as much as 19% over the course of the cycle. The researchers found that...
by Elizabeth Kissling | Jul 19, 2010 | Menopause, New Research, Pharmaceutical
Guest post by Jerilynn Prior, Centre for Menstrual Cycle and Ovulation Research It’s been two weeks since Chris Hitchcock and I returned from San Diego’s recent Endocrine Society meetings. We are feeling incredibly happy with the success of our protracted, intense...
by Elizabeth Kissling | Jun 23, 2010 | Menopause, New Research, Pharmaceutical
The Endocrine Society has released a new, peer-reviewed statement on the risks and benefits of hormone therapy for menopausal women. The upshot is that risks and benefits vary depending on the age of the patient and the length of time since menopause: One interesting...
